These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [K/DOQI clinical practice guidelines for management of renal osteodystrophy in predialysis patients]. Okada N; Tsubakihara Y Clin Calcium; 2004 May; 14(5):698-706. PubMed ID: 15577030 [TBL] [Abstract][Full Text] [Related]
3. Renal osteodystrophy. Coburn JW; Henry DA Adv Intern Med; 1984; 30():387-424. PubMed ID: 6397042 [TBL] [Abstract][Full Text] [Related]
4. [Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification]. Fournier A; Aparicio M Nephrologie; 1998; 19(3):129-30. PubMed ID: 9633056 [No Abstract] [Full Text] [Related]
5. [Therapy for ROD and measurement of the bone mass]. Yamamoto I; Kawamura Y; Hirano K; Hayakawa H; Shigematu T Clin Calcium; 2004 Dec; 14(12):83-8. PubMed ID: 15577179 [TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and treatment of renal osteodystrophy. Slatopolsky E; Gonzalez E; Martin K Blood Purif; 2003; 21(4-5):318-26. PubMed ID: 12944733 [TBL] [Abstract][Full Text] [Related]
8. Renal osteodystrophy: review of the disease and its treatment. El-Kishawi AM; El-Nahas AM Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):373-82. PubMed ID: 16970258 [TBL] [Abstract][Full Text] [Related]
9. [Renal osteodystrophy and its possible correction in patients on chronic hemodialysis]. Rozental' RL; Babarykin DA; Tikhomirova TE; Il'inskiĭ IM; Chernevskis KhK Ter Arkh; 1986; 58(1):105-8. PubMed ID: 3961679 [TBL] [Abstract][Full Text] [Related]
10. Early treatment of renal osteodystrophy. Mehls O; Ritz E Contrib Nephrol; 1984; 37():52-7. PubMed ID: 6546912 [No Abstract] [Full Text] [Related]
11. Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy. Hernandez JD; Wesseling K; Salusky IB Semin Dial; 2005; 18(4):290-5. PubMed ID: 16076350 [TBL] [Abstract][Full Text] [Related]
12. Renal osteodystrophy in children with end-stage kidney failure. Chan JC Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255 [TBL] [Abstract][Full Text] [Related]
13. Managing bone mineral disorders in CKD: an overview of current therapies. Delaney M J Ren Care; 2009 Mar; 35 Suppl 1():107-10. PubMed ID: 19222741 [No Abstract] [Full Text] [Related]
14. Prevention of renal osteodystrophy. Baker LR Miner Electrolyte Metab; 1991; 17(4):240-9. PubMed ID: 1813786 [TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus. Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311 [TBL] [Abstract][Full Text] [Related]
16. Current status of the management of renal osteodystrophy. Fournier A; Sebert JL; Coevoet B; De Fremont JF; Hardin JM; Lambrey G Proc Eur Dial Transplant Assoc; 1978; 15():547-68. PubMed ID: 368790 [No Abstract] [Full Text] [Related]
17. Severe renal osteodystrophy without elevated serum immunoreactive parathyroid hormone concentrations in hypomagnesemia due to renal magnesium wasting. Zelikovic I; Dabbagh S; Friedman AL; Goelzer ML; Chesney RW Pediatrics; 1987 Mar; 79(3):403-9. PubMed ID: 3822640 [TBL] [Abstract][Full Text] [Related]